Hydromorphone Aristo (Hydromorphone Hydrochloride)

Hydromorphone is an opioid analgesic that acts on the central nervous system to relieve pain. It is indicated for:

• Acute postoperative pain: provides rapid and effective analgesia after surgery.
• Cancer‑related pain: helps control severe nociceptive pain associated with malignancy.
• Chronic non‑cancer pain: used when other analgesics are insufficient to manage persistent severe pain.
• Severe breakthrough pain: offers fast relief for sudden spikes in pain intensity.

• Hydromorphone binds selectively to μ‑opioid receptors in the brain and spinal cord, activating inhibitory G‑protein pathways that reduce neuronal excitability. This action decreases the release of neurotransmitters involved in pain transmission, leading to diminished perception of pain and increased pain tolerance.

Hydromorphone may cause a range of adverse reactions. Monitoring and patient education are essential.

Common Side Effects

• Nausea: feeling of sickness or urge to vomit.
• Constipation: reduced bowel movements and hard stools.
• Drowsiness: increased sleepiness or fatigue.
• Dry mouth: reduced salivation leading to a parched feeling.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing dizziness or fainting.
• Anaphylaxis: rare allergic reaction with rash, swelling, and airway compromise.

Before prescribing Hydromorphone, clinicians should consider several safety measures.

• Assess pain severity: confirm that opioid therapy is appropriate for the level of pain.
• Monitor respiratory function: watch for signs of slowed breathing, especially after dose changes.
• Use lowest effective dose: titrate to the minimum dose that provides adequate relief.
• Caution in respiratory disease: avoid or use with extreme caution in patients with severe asthma or COPD.
• Adjust for organ impairment: consider dose reduction in renal or hepatic dysfunction.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Hydromorphone can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid)

• Other central nervous system depressants (e.g., benzodiazepines, alcohol): may cause profound respiratory depression.
• Monoamine oxidase inhibitors (MAOIs): increase risk of serotonin syndrome and hypertensive reactions.
• Concurrent opioid therapy: additive effects on sedation and respiratory depression.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise hydromorphone plasma levels.
• Antihistamines and anticholinergics: can enhance drowsiness and anticholinergic side effects.
• Diuretics: may exacerbate hypotension when combined with opioid‑induced vasodilation.